Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
activated protein C resistance
anemia
anemia, hemolytic
angiography, cerebral
anticoagulant, complications of
anticoagulant, treatment in CVD
antithrombin III deficiency
blood dyscrasias, neurologic findings with
Budd-Chiari Syndrome
CAT scan, abdomen
cerebral edema, origin and treatment
cerebral infarction, hemorrhagic
cerebral ischemia
cerebral venous thrombosis
cerebrovascular accident
cerebrovascular accident, work up for
Clinical Pathologic Conference(C.P.C.)
congestive heart failure
corneal dystrophy
cryofibrinogenemia
dehydration
diabetes mellitus
disseminated intravascular coagulation(DIC)
dural sinus thrombosis
eculizumab
eye movement, painful
head injury
headache
headache, severe
hemianopia
hemoglobinuria
hemolysis
intracerebral hemorrhage
intracranial pressure, increased
lactic dehydrogenase(LDH)
leukemia
leukemia, neurologic findings assoc.with
monoclonal antibodies
MRI, abnormal
myeloproliferative disorder
neurologic disease, diagnoses of
oral contraceptives
oral contraceptives, cerbrovascular disease and
oral contraceptives, neurologic complications with
pain, abdominal
papilledema
paroxysmal nocturnal hemoglobinuria
plasminogen deficiency
polycythemia, primary
pregnancy, neurologic complications in
primary thrombocythemia
protein C deficiency
protein S deficiency
review article
seizure
sickle cell disease
sickle cell trait
splenic-vein thrombosis
splenomegaly
superior sagittal sinus thrombosis
thrombocytopenia
thrombophlebitis
treatment of neurologic disorder
ulcerative colitis
Showing articles 350 to 400 of 1161 << Previous Next >>

Subclinical Atrial Fibrillation and the Risk of Stroke
NEJM 366:120-129,178, Healey, J.S., et al, 2012

Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum
JNNP 83:124-137, Charidimou,A.,et al, 2012

New Antithrombotic Drugs for Atrial Fibrillation: Caution is Needed
Lancet 379:e24, Bell,S.,et al, 2012

Self-Monitoring of Oral Anticoagulation: Systematic Review and Meta-Analysis of Individual Patient Data
Lancet 379:322-34, Heneghan,C., 2012

Anticoagulant Loses its Lustre
Lancet 379:301, Mullar,A., 2012

Clincopathologic Conference,Graves Disease with Thyrotoxic Periodic Paralysis
NEJM 366:553-560, Case 4-2012, 2012

Cost-Effectiveness of Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Stroke 43:881-883, Kamel,H.,et al, 2012

Critique of Apixaban Versus Warfarin in Patients with Atrial Fibrillation
Stroke 43:922-923, Nedeltchev,K, 2012

Syncope: A Rare Manifestation of a Common Condition
Lancet 379:866, Hogarth,A.,et al, 2012

Progress for Stroke Prevention with Atrial Fibrillation
Stroke 43:1179-1185, Katsnelson,M.,et al, 2012

Electrophysiological Study with Prophylactic Pacing and Survival in Adults with Myotonic Dystrophy and Conduction System Disease
JAMA 307:1292-1301, Wahbi,K.,et al, 2012

Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012

Clinicopathologic Conference, Ileocolonic Intussusception Associated with Syncope (Neurologic Intussusception)
NEJM 366:1522-1536, Case 12-2012, 2012

Evidence-based Guideline Update: NSAIDs and Other Complementary Treatments for Episodic Migraine Prevention in Adults
Neurol 78:1346-1353, Holland,S.,et al, 2012

Evidence-based Guideline Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults
Neurol 78:1337-1345, Silberstein,S.D.,et al, 2012

Botulinum Toxin A for Prophylactic Treatment of Migraine and Tension Headaches in Adults
JAMA 307:1736-1745, Jackson,J.L.,et al, 2012

Clinicopathologic Conference, Neurocysticercosis Involving the Cerebral Ventricles and Spinal Meninges
NEJM 366:1924-1934, Case 15-2012, 2012

Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack
NEJM 366:1914-1922;, Davis, S.M. & Donnan, G.A., 2012

Clinicopathologic Conference, Glioblastonoma, WHO grade IV of IV, with Methylation of the MGMT Promoter
NEJM 366:2112-2120, Case 17-2012, 2012

Intracraial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation with Warfarin or Dabigatran
Stroke 43:1511-1517, Hart, R.G.,et al, 2012

Spinal Haemorrhage During Anticoagulant Regimen for Thromboprophylaxis: A Unique Form of Central Nervous System Haemorrhage
JNNP 83:746-752, Furlan, J.C.,et al, 2012

A Prescription for the Epley Maneuver: www.youtube.com?
Neurol 79:376-380, Kerber, K.A.,et al, 2012

Clinical Reasoning: Encephalopathy in a 10-year-old boy
Neurol 79:e12-e18, Rodan, L. & Tein, I., 2012

LMNA Cardiomyopathy:Cell Biology and Genetics Meet Clinical Medicine
Disease Models & Mechanisms 4:562-568, Lu,J.T., et al, 2011

Epstein-Barr Virus Infections of the Nervous System
www.medlink.com, Nov, Amlie-Lefond,C., 2011

Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation
Stroke 42:112-118, Mercaldi,C.J.,et al, 2011

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011

New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF
JAMA 305:25-26, Mitka,M., 2011

Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011

Temporal Onset, Risk Factors, and Outcomes Associated With Stroke After Coronary Artery Bypass Grafting
JAMA 305:381-390, Tarakji,K.G.,et al, 2011

Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:512-584, Goldstein,L.B.,et al, 2011

Restenosis After Carotid Surgery: The Importance of Clinical Presentation and Preoperative Timing
Stroke 42:965-971, van Lammeren,G.W.,et al, 2011

Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
Stroke 42:1717-1721, Jowett, S.,et al, 2011

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study
BMJ 343:d3450, Schmidt, M.,et al, 2011

Apixaban in Atrial Fibrillation From Bleeding Cows to 21st Century Medicinal Chemistry
Stroke 42:2376-2378, Cucchiara, B.L.,et al, 2011

Improved Late Survival and Disability After Stroke With Therapeutic Anticoagulation for Atrial Fibrillation
Stroke 42:2503-2508, Hannon, N.,et al, 2011

Stroke Recurrence within the Time Window Recommended for Carotid Endarterectomy
Neurol 77:738-743, Marrane, M.,et al, 2011

An Acutely Confused Young Woman
Lancet 378-456, Casetta, I,.et al, 2011

Analysis of Relapses in Anti-NMDAR Encephalitis
Neurol 77:996-999, Gabilondo, I.,et al, 2011

Rivaroxaban versus Warfarin in Nonvavular Atrial Fibrillation
NEJM 365:883-891, 952, Patel, M.R.,et al, 2011

Apixaban versus Warfarin in Patients with Atrial Fibrillation
NEJM 365:981-992,1052, Granger, C.B.,et al, 2011

Clinical Reasoning: A 34-year-old man with recurrent limb weakness
Neurol 77:e68-e72, Karam, C.,et al, 2011

Differential Features of Carotid and Vertebral Artery Dissections
Neurol 77:1174-1181, Debette, S.,et al, 2011

Chronic Heart Failure and Ischemic Stroke
Stroke 42:2977-2982, Haeusler, K.G.,et al, 2011

GFAP Mutations, Age at Onset, and Clinical Subtypes in Alexander Disease
Neurol 77:1287-1294, Prust, M.,et al, 2011

Clinicopathologic Conference, Limbic Encephaitis with Antibodies to Leucine - Rich Glioma - inactivated 1 (LGI 1).
NEJM 365:1825-1833, Case 34-2011, 2011

Dabigatran Etexilate versus Warfarin in Management of Non-Valvular Atrial Fibrillation in UK Context: Quantitative Benefit-Harm and Economic Analyses
BMJ 343:d6333, Pink, J.,et al, 2011

A New Landscape for Stroke Prevention in Atrial Fibrillation
Stroke 42:3316-3322, Banerjee, A.,et al, 2011

Long-term Cognitive Outcomes Following Out-of-Hospital Cardiac Arrest
Neurol 77:1438-1445, Mateen, F.J.,et al, 2011

Seizure Recurrence After Antiepileptic Drug Withdrawal and the Implications for Driving: Further Results from the MRC Antiepileptic Drug Withdrawal Study and a Systematic Review
JNNP 82:1328-1333, Bonnett, L.J.,et al, 2011



Showing articles 350 to 400 of 1161 << Previous Next >>